...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >DEVELOPMENT OF MUCOADHESIVE DELIVERY OF CHLORZOXAZONE POLYETHYLENE GLYCOL SOLID DISPERSION
【24h】

DEVELOPMENT OF MUCOADHESIVE DELIVERY OF CHLORZOXAZONE POLYETHYLENE GLYCOL SOLID DISPERSION

机译:氯唑酮聚乙烯乙二醇固体分散体粘胶递送的研究

获取原文

摘要

Objective: Chlorzoxazone (CLZ) is centrally acting skeletal muscle relaxant. It is insoluble in water, so employed for the formation of solid dispersions(SD) as a means to enhance the dissolution rate, and carrier selected was polyethylene glycol 6000 (PEG 6000).Methods: The SDs were prepared by different methods and characterized by in vitro drug release, drug content, fourier transform infraredspectroscopy (FTIR), differential scanning calorimetry, powder X-ray diffraction. All the SD showed dissolution improvement compare to pure drug.These techniques revealed distinct loss of drug crystallinity in the formulation accounting for enhancement in dissolution rate. The SD methodsshowing best in vitro drug release profile were selected in the further development of mucoadhesive buccal patches. A buccal patch has been developedusing two mucoadhesive polymers, i.e. hydroxyl propyl methyl cellulose K4M and carbopol 974. The patches were evaluated for the physicochemical,mechanical and drug release characteristics. The optimized patches showed good mechanical and physicochemical properties to withstand theenvironment of the oral cavity. The in-vitro permeation study showed that patches could deliver drug to the oral mucosa for a period of 8 hrs.Results: The results indicate that suitable bioadhesive buccal patches with good permeability could be prepared. The batches FH4 and FC4 showed81.95% and 79.97% permeated through goat mucosa membrane in 8 hrs. The physicochemical interactions were investigated by FTIR, showed noany evidence of interactions and were present in an unchanged state. The stability study for SD and buccal patch carried out revealed that were stablefor a period of 3-month.Conclusion: Phase-solubility studies indicate significantly increase in solubility. The optimized buccal patches showed good mechanical andphysicochemical properties to withstand environment of the oral cavity.
机译:目的:氯唑沙宗(CLZ)是中枢作用的骨骼肌松弛剂。它不溶于水,因此可用于形成固体分散体(SD)以提高溶解速度,所选择的载体是聚乙二醇6000(PEG 6000)。方法:通过不同的方法制备SD,并通过以下方法表征体外药物释放,药物含量,傅立叶变换红外光谱(FTIR),差示扫描量热法,粉末X射线衍射。与纯药物相比,所有SD均显示出溶出度改善。这些技术揭示了制剂中药物结晶度的明显损失,这说明了溶出度的提高。在粘膜粘膜颊贴的进一步开发中选择了显示最佳体外药物释放曲线的SD方法。使用两种粘膜粘附性聚合物,即羟丙基甲基纤维素K4M和carbopol 974,开发了一种颊贴剂。对该贴剂的理化,机械和药物释放特性进行了评估。优化的贴剂具有良好的机械和物理化学性能,可以抵抗口腔环境。体外渗透研究表明,贴剂可以在8小时内将药物递送至口腔粘膜。结果:结果表明,可以制备合适的具有良好渗透性的生物粘附颊贴剂。批次FH4和FC4在8小时内透过山羊粘膜渗透了81.95%和79.97%。 FTIR对理化相互作用进行了研究,没有发现任何相互作用的证据,并且以不变的状态存在。对SD和颊贴的稳定性研究表明其在3个月内是稳定的。结论:相溶解度研究表明溶解度显着增加。优化的口腔贴片具有良好的机械和物理化学性能,可以抵抗口腔环境。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号